Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Shanghai Innostar Biotechnology Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Shanghai Innostar Biotechnology has a total shareholder equity of CN¥1.6B and total debt of CN¥246.5M, which brings its debt-to-equity ratio to 15%. Its total assets and total liabilities are CN¥2.8B and CN¥1.1B respectively. Shanghai Innostar Biotechnology's EBIT is CN¥158.9M making its interest coverage ratio -19.5. It has cash and short-term investments of CN¥1.2B.
Anahtar bilgiler
15.0%
Borç/özkaynak oranı
CN¥246.50m
Borç
| Faiz karşılama oranı | -19.5x |
| Nakit | CN¥1.16b |
| Eşitlik | CN¥1.64b |
| Toplam yükümlülükler | CN¥1.14b |
| Toplam varlıklar | CN¥2.78b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 688710's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥881.3M).
Uzun Vadeli Yükümlülükler: 688710's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥254.6M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 688710 has more cash than its total debt.
Borcun Azaltılması: Insufficient data to determine if 688710's debt to equity ratio has reduced over the past 5 years.
Borç Kapsamı: 688710's debt is well covered by operating cash flow (35.4%).
Faiz Kapsamı: 688710 earns more interest than it pays, so coverage of interest payments is not a concern.